Gene · 2931
Papers2,889
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,889
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative characteristics between calyculin A-induced and thimerosal-induced hyperactivation of cryopreserved bovine spermatozoa. | J Reprod Dev | 2023 | 37081666 | PubTator, text mining | PubMed |
| Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification. | J Proteome Res | 2023 | 37071664 | PubTator, text mining | PubMed |
| Strategies targeting PD-L1 expression and associated opportunities for cancer combination therapy. | Theranostics | 2023 | 37056572 | PubTator, text mining | PubMed |
| Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases. | Mini Rev Med Chem | 2023 | 37055897 | PubTator, text mining | PubMed |
| Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells. | Cell Death Dis | 2023 | 37055381 | PubTator, text mining | PubMed |
| Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens. | Proc Natl Acad Sci U S A | 2023 | 37036970 | PubTator, text mining | PubMed |
| Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β? | Front Neurosci | 2023 | 37034173 | PubTator, text mining | PubMed |
| Deciphering the Clinical Significance and Kinase Functions of GSK3α in Colon Cancer by Proteomics and Phosphoproteomics. | Mol Cell Proteomics | 2023 | 37031867 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| ITGB1-mediated molecular landscape and cuproptosis phenotype induced the worse prognosis in diffuse gastric cancer. | Front Oncol | 2023 | 37007126 | PubTator, text mining | PubMed |
| Machine learning-based predictive models and drug prediction for schizophrenia in multiple programmed cell death patterns. | Front Mol Neurosci | 2023 | 36993785 | PubTator, text mining | PubMed |
| TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway. | Cell Biosci | 2023 | 36991473 | PubTator, text mining | PubMed |
| mRNA translational specialization by RBPMS presets the competence for cardiac commitment in hESCs. | Sci Adv | 2023 | 36989351 | PubTator, text mining | PubMed |
| Genetic Networks of Alzheimer's Disease, Aging, and Longevity in Humans. | Int J Mol Sci | 2023 | 36982253 | PubTator, text mining | PubMed |
| Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. | Cancers (Basel) | 2023 | 36980587 | PubTator, text mining | PubMed |
| Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease. | Antioxidants (Basel) | 2023 | 36978988 | PubTator, text mining | PubMed |
| Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. | J Transl Med | 2023 | 36973787 | PubTator, text mining | PubMed |
| Role of regulation of PD-1 and PD-L1 expression in sepsis. | Front Immunol | 2023 | 36969168 | PubTator, text mining | PubMed |
| Integrative proteogenomic characterization of early esophageal cancer. | Nat Commun | 2023 | 36966136 | PubTator, text mining | PubMed |
| Modeling structure-activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics. | Front Endocrinol (Lausanne) | 2023 | 36950681 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2931/papers?page=12